ABCL

#2371
AbCellera Biologics Inc. Common Shares
3.76 USD
+2.73%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
3.76
3.76
Rango anual
1.94
6.52
Cambio diario
+2.73%
Variación mensual
+6.52%
Variación en los últimos 6 meses
-33.69%
Cambio anual
+55.37%
Cierres anteriores
3.66
Abrir
3.76
Bid
Ask
Mínimo
3.76
High
3.76
Volumen
45
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 20212022202320242025 TTM

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Noticias